FDA Authorizes a Second Artificial Pancreas System
Tandem’s FDA-approved Control IQ system is a major improvement over other loop systems and is expected to hit the market in early 2020
In a win for all people with type 1 diabetes (even those who won’t directly benefit from this closed-loop system), the FDA has approved Tandem’s new Control IQ software for release in 2020.
This new automated glycemic control algorithm is just the second hybrid closed-loop system available to patients with an FDA clearance. And it promises tighter control, easier usability, and more customization than the current 670g automated system from Medtronic.
Lilly’s Baqsimi is a needle-free, simple treatment for severe hypoglycemia – bringing long-needed innovation to use of glucagon in emergency settings.
Include $99 Insulin in the US from Novo Nordisk
$99 Cash Card Program for Analog Insulins:
Using My$99Insulin, people with diabetes will be able to purchase up to three vials or two packs of FlexPen/FlexTouch pens with any combination of Novo Nordisk analog insulins (NovoLog, Tresiba, Fiasp) for $99. Depending on the brand, this is about 3000-3800 units of insulin. The company suggests that this supply of insulin will cover the monthly needs of most people with diabetes. People can use the My$99insulin card as often as they need to.